|Articles|February 1, 2006

Volume 0

Press-In Bottle Adapter

EPS Inc(Ivyland, Pa)recently introducedtheEPS Press-InBottle Adapter.The productallowshealth careprofessionalsto easilydispense liquidsfromstock bottles into oral syringes. Professionalsjust need to press the adapterinto the bottle's opening and attach theoral syringe to the adapter's port. Then,withdraw the dose of medication fromthe bottle. The EPs' Press-In BottleAdapter is available in 24-, 28-, and 33-mm sizes. Packaged in bags of 25, theproduct fits most TampAlerT and EPSPrescription Bottles and can be usedwith the EPS line of oral syringes. Formore information, call 800-523-8966, orvisit www.medi-dose.com.

Articles in this issue

almost 20 years ago

Article

can you READ these Rxs?

almost 20 years ago

Article

Compounding HOTLINE

almost 20 years ago

Article

A Quarter Century of Pharmacy Law—And the Fat Lady Is Singing

almost 20 years ago

Article

It's Time for Education on Rx Drug Abuse

almost 20 years ago

Article

Improving Quality of Life for Psoriasis Patients

almost 20 years ago

Article

A Look at Diabetic Retinopathy

almost 20 years ago

Article

The Graying of HIV

almost 20 years ago

Article

AutoCarousel

almost 20 years ago

Article

Lexi-Comp Knowledge Solution

almost 20 years ago

Article

Refill TeleManager

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

Virtual Symposium Registration

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

November 5, 2025 | 7:00 PM

Virtual Event

Asembia Specialty Pharmacy Day of Education 2025

Thursday, November 6, 2025

Virtual Symposium Registration

Addressing Gaps in Care for Hyperkalemia With Novel Oral Potassium Binding Agents

November 12, 2025 | 4:00 PM ET

Webinar Registration

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

November 12, 2025 | 1:00 PM & 8:00 PM ET

Webinar Registration

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

November 12, 2025 | 1:00 PM & 8:00 PM ET

Webinar Registration

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

November 13, 2025 | 1:00 PM & 8:00 PM ET

On-Demand Virtual Symposium

Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Risk Populations and Vaccine Uptake

1.0 Credit / Immunization, Infectious Diseases

On-Demand Virtual Symposium

Glucagon for Diabetes: Overcoming Barriers for Optimal Management in the Long-Term Care Setting

1.0 Credit / Endocrinology, Diabetes & Metabolism

Press-In Bottle Adapter

Articles in this issue

Newsletter

Related Content

Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry

Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults

Recognizing Immunizing Pharmacists in the Community

Accelerated Approval of Cancer Drugs: Benefit or Burden?

Burnout Among Pharmacy Technicians Demands Urgent Action

Latest CME

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Asembia Specialty Pharmacy Day of Education 2025

Addressing Gaps in Care for Hyperkalemia With Novel Oral Potassium Binding Agents

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Risk Populations and Vaccine Uptake

Glucagon for Diabetes: Overcoming Barriers for Optimal Management in the Long-Term Care Setting

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Directions in Oncology Pharmacy® 2025: Northeast

Transforming Small Cell Lung Cancer Management With DLL3-Targeted Therapies

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Advancing Chronic Kidney Disease Detection and Cardiovascular Risk Reduction in Complex Patients

Cytokine Release Syndrome With Bispecific Antibodies: A Pharmacist's Guide to Safe Management

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Enhancing Endometrial Cancer Management: Highlights of Molecular Insights, Treatment Approaches, and Toxicity Management

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Enhancing Safety in Cancer Care: Expert Guidance on Toxicity Management of HER2, TROP2, and HER3-Targeted Antibody-Drug Conjugates

Exploring the Role of Glucagon Like Peptide Receptor 1 Agonists (GLP-1RA) in the Treatment of Obesity (Pharmacist Credit)

A Pharmacist's Guide to the Safe and Effective Management of BTK and BCL-2 inhibitors in Chronic Lymphocytic Leukemia

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians (Pharmacy Technician Credit)

ASHP Midyear 2025

Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Lymphomas: A Practical Guide for Pharmacists

Overview and Burden of Migraine

Advancements in Extensive-Stage Small Cell Lung Cancer Therapy: Integrating Clinical Evidence to Fill Gaps in Care

The Evolving Treatment Landscape of Migraine

Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes

Emerging Biologic Therapy for the Management of COPD: Integrated Approaches to Optimized Care

The Impact and Role of Pharmacists in the Management of Specialty Therapies

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

Exploring Advances in the Management of DOAC-Associated Bleeding With Reversal Agents: Role of the Health-System Pharmacists

Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

Navigating Diabetes: A Guide to Effective Oral Treatments

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

The Role of the Pharmacist in the Management of Hyperlipidemia

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis (Pharmacy Technician Credit)

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Beyond the Spots: Management of Measles

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Tracking a Moving Target in HR+ Metastatic Breast Cancer: Innovative Oral Therapies and Evolving Strategies

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Advancing Care in HER2-Negative Early Breast Cancer: Essential Insights and Best Practices for Oncology Pharmacists

Expanding Access to Antibody-Based Regimens in Relapsed/Refractory Multiple Myeloma

Navigating the World of Insulin: An Update on Types, Uses, and Considerations

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

JAK(i) of All Trades: Navigating Myelofibrosis Treatment and Safety in Community Oncology Practice

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Aiming for Accuracy in Non-Small Cell Lung Cancer Treatment: Precision Strategies for Oncology Pharmacists

Beyond Chimeric Antigen Receptor T-Cell Therapy: Comprehensive Approaches for Community Oncology Practices in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Advancing Chronic Lymphocytic Leukemia Treatment in the Community: Practical Updates and Clinical Pearls for Oncology Pharmacists

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Shaping the Future of Renal Cell Carcinoma: A Case-Based Exploration of Emerging Treatment and Improved Patient Outcomes

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches